CHARACTERIZATION OF THE EXPRESSION AND IMMUNOGENICITY OF POLIOVIRUS REPLICONS THAT ENCODE SIMIAN IMMUNODEFICIENCY VIRUS SIV(MAC)239 GAG OR ENVELOPE SU PROTEINS
Mj. Anderson et al., CHARACTERIZATION OF THE EXPRESSION AND IMMUNOGENICITY OF POLIOVIRUS REPLICONS THAT ENCODE SIMIAN IMMUNODEFICIENCY VIRUS SIV(MAC)239 GAG OR ENVELOPE SU PROTEINS, AIDS research and human retroviruses, 13(1), 1997, pp. 53-62
The effectiveness of the poliovirus vaccines to induce both systemic a
nd mucosal immunity has prompted the development of this virus as a ve
ctor in which to express foreign proteins. Our laboratory has previous
ly reported on the construction and characterization of poliovirus gen
omes that encode HIV-1 proteins (Porter DC, et al.: 3 Virol 1996;70:26
43-2649). To develop this system further, we have constructed poliovir
us genomes, referred to as replicons, which encode the SIV(mac)239 Gag
or Env SU in place of the poliovirus capsid gene (Pi). Since the repl
icons do not encode capsid proteins, they are encapsidated into poliov
irions by passage with a recombinant vaccinia virus, WP1, which provid
es the poliovirus capsid proteins in trans. Using this system, we have
derived stocks of the encapsidated replicons which encode the SIV(mac
)239 Gag or Env SU protein. Infection of cells with the replicon that
encodes SIV(mac)239 Gag resulted in the expression of a 55-kDa protein
that was released from the infected cells. Analysis of the sedimentat
ion of the released proteins by sucrose density gradient centrifugatio
n revealed that the protein was released from the cell in the form of
a virus-like particle. Infection of cells with the replicons encoding
the SIV(mac)239 Env SU resulted in the expression of a 63-kDa protein,
corresponding to the molecular mass predicted for the nonglycosylated
SIV(mac)239 SU protein. A second protein with a molecular mass greate
r than 160 kDa was also immunoprecipitated. After enzymatic deglycosyl
ation, this protein migrated at a molecular mass consistent with that
for an Env SU diner. Analysis of the medium from cells infected with t
he replicon encoding SIV(mac)239 Env SU revealed the presence of a pro
tein of molecular mass 85-90 kDa, possibly representing a fragment of
the SIV(mac)239 Env SU protein. To determine the immunogenicity of the
replicons encoding SIV(mac)239 Gag or Env SU, transgenic mice that ex
press the human receptor for poliovirus, and are thus susceptible to p
oliovirus, were immunized via the intramuscular route. A serum antibod
y response to SIV envelope was detected following booster immunization
, establishing that the encapsidated replicon was immunogenic. Finally
, we demonstrate that the replicons have the capacity to infect periph
eral blood mononuclear monocytes/macrophages, suggesting that this cel
l is a possible target for in vivo infection. The results of our studi
es, then, lend further support for the development and application of
recombinant poliovirus replicons in a vaccine strategy.